We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$95.6M
Cap. Flow
+$79.9M
Cap. Flow %
4.52%
Top 10 Hldgs %
10.21%
Holding
1,825
New
561
Increased
356
Reduced
388
Closed
510

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$21.7M
2
HLF icon
Herbalife
HLF
+$20.4M
3
TXRH icon
Texas Roadhouse
TXRH
+$18M
4
BKNG icon
Booking.com
BKNG
+$17.7M
5
LOW icon
Lowe's Companies
LOW
+$15.5M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$14.3M
2
UPS icon
United Parcel Service
UPS
+$10.8M
3
LULU icon
lululemon athletica
LULU
+$9.52M
4
AMZN icon
Amazon
AMZN
+$8.2M
5
GILD icon
Gilead Sciences
GILD
+$7.98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.14%
2 Technology 14.57%
3 Healthcare 11.17%
4 Industrials 9.82%
5 Financials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADXS
1251
DELISTED
Advaxis Inc
ADXS
$46K ﹤0.01%
+21,898
New +$69.4K
CKPT
1252
DELISTED
Checkpoint Therapeutics
CKPT
$45K ﹤0.01%
+1,492
New +$58.6K
DSX icon
1253
Diana Shipping
DSX
$270M
$45K ﹤0.01%
19,265
-2,739
-12% -$6.01K
LXU icon
1254
LSB Industries
LXU
$822M
$44K ﹤0.01%
+14,707
New +$56.1K
SVRA icon
1255
Savara
SVRA
$1.09B
$44K ﹤0.01%
18,652
+1,039
+6% +$9.23K
AIM
1256
AIM ImmunoTech
AIM
$6.54M
$44K ﹤0.01%
+100
New +$60.5K
DF
1257
DELISTED
Dean Foods Company
DF
$43K ﹤0.01%
+46,198
New +$74.3K
TNXP icon
1258
Tonix Pharmaceuticals
TNXP
$158M
0
CRDF icon
1259
Cardiff Oncology
CRDF
$63.6M
$41K ﹤0.01%
16,597
-2,082
-11% -$6.68K
RNAC icon
1260
Cartesian Therapeutics
RNAC
$225M
$40K ﹤0.01%
+739
New +$50.4K
WPRT
1261
Westport Fuel Systems
WPRT
$32.9M
$40K ﹤0.01%
+1,478
New +$32.8K
LEE icon
1262
Lee Enterprises
LEE
$177M
$37K ﹤0.01%
+1,674
New +$45.8K
CRR
1263
DELISTED
Carbo Ceramics Inc.
CRR
$37K ﹤0.01%
+27,257
New +$60.2K
TRVN
1264
DELISTED
Trevena, Inc.
TRVN
$36K ﹤0.01%
+56
New +$46.1K
HSDT icon
1265
Solana Company
HSDT
$98.7M
0
LRMR icon
1266
Larimar Therapeutics
LRMR
$398M
$35K ﹤0.01%
+2,423
New +$64.5K
OSG
1267
DELISTED
Overseas Shipholding Group Inc.
OSG
$35K ﹤0.01%
18,642
-2,100
-10% -$3.89K
EMKR
1268
DELISTED
Emcore Corp
EMKR
$35K ﹤0.01%
1,063
+10
+0.9% +$372
ALTO icon
1269
Alto Ingredients
ALTO
$345M
$34K ﹤0.01%
+44,157
New +$45.1K
NUWE icon
1270
Nuwellis
NUWE
$178K
0
AGFS
1271
DELISTED
AgroFresh Solutions Inc
AGFS
$34K ﹤0.01%
+22,269
New +$58.2K
CDR
1272
DELISTED
Cedar Realty Trust, Inc
CDR
$34K ﹤0.01%
1,944
-7,728
-80% -$155K
SREV
1273
DELISTED
ServiceSource International, Inc.
SREV
$34K ﹤0.01%
35,344
+16,489
+87% +$16.3K
LCTX icon
1274
Lineage Cell Therapeutics
LCTX
$267M
$33K ﹤0.01%
+29,731
New +$34.3K
NIHD
1275
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$32K ﹤0.01%
18,988
+4,540
+31% +$8.65K

Similar funds

A.R.T. Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, A.R.T. Advisors held 1,825 positions worth $1.77B, up 5.7% from $1.67B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

A.R.T. Advisors deployed $79.9M of net new capital in Q2 2019, opening 561 new positions and adding to 356 existing holdings. Its largest new stake was Nike: 257,500 shares worth $21.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was lululemon athletica, an estimated $9.52M trimmed.

  • A.R.T. Advisors's largest Q2 2019 buy was Nike: 257,500 shares worth $21.6M.
  • A.R.T. Advisors added most to Herbalife in Q2 2019, an estimated $20.4M increase.
  • A.R.T. Advisors's biggest Q2 2019 reduction was lululemon athletica, cutting an estimated $9.52M.
  • A.R.T. Advisors fully exited Starbucks in Q2 2019, selling an estimated $14.3M.
  • A.R.T. Advisors's ten largest holdings make up 10% of its $1.77B portfolio in Q2 2019.
  • A.R.T. Advisors opened 561 new positions and closed 510 in Q2 2019.
  • A.R.T. Advisors's portfolio value rose 5.7% quarter-over-quarter to $1.77B.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.